← FDA DRUG APPROVALS

FDA ANDA · ANDA063282

CLINDAMYCIN PHOSPHATE

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA063282
TYPE
ANDA
ORIGINAL APPROVAL
1992-05-29
LATEST ACTION
2000-01-20
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CLINDAMYCIN PHOSPHATEDiscontinued
CLINDAMYCIN PHOSPHATE EQ 150MG BASE/ML · INJECTABLE · INJECTION

Approval history

2000-01-20Labeling · Supplement 2AP
1994-01-07Manufacturing (CMC) · Supplement 1AP
1992-05-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →